267 related articles for article (PubMed ID: 27085607)
1. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
[TBL] [Abstract][Full Text] [Related]
2. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
3. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
Kohler RJ; Perrine SA; Baker LE
Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
[TBL] [Abstract][Full Text] [Related]
4. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
Risca HI; Zuarth-Gonzalez JD; Baker LE
Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
[TBL] [Abstract][Full Text] [Related]
5. Cyanidin prevents MDPV withdrawal-induced anxiety-like effects and dysregulation of cytokine systems in rats.
Inan S; Meissler JJ; Shekarabi A; Foss J; Wiah S; Eisenstein TK; Rawls SM
Brain Res; 2023 May; 1806():148310. PubMed ID: 36871847
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.
Gentile TA; Simmons SJ; Tallarida CS; Su S; Rom S; Watson MN; Reitz AB; Potula R; Rawls SM
Drug Alcohol Depend; 2019 Apr; 197():22-27. PubMed ID: 30754021
[TBL] [Abstract][Full Text] [Related]
8. Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.
Oliver CF; Simmons SJ; Nayak SU; Smith GR; Reitz AB; Rawls SM
Drug Alcohol Depend; 2018 May; 186():75-79. PubMed ID: 29550625
[TBL] [Abstract][Full Text] [Related]
9. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
Berquist MD; Traxler HK; Mahler AM; Baker LE
Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
11. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
[TBL] [Abstract][Full Text] [Related]
12. Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.
Gannon BM; Russell LN; Modi MS; Rice KC; Fantegrossi WE
Drug Alcohol Depend; 2017 Oct; 179():408-415. PubMed ID: 28866386
[TBL] [Abstract][Full Text] [Related]
13. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
[TBL] [Abstract][Full Text] [Related]
14. Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood.
López-Arnau R; Luján MA; Duart-Castells L; Pubill D; Camarasa J; Valverde O; Escubedo E
Br J Pharmacol; 2017 May; 174(10):1161-1173. PubMed ID: 28262947
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
[TBL] [Abstract][Full Text] [Related]
16. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
[TBL] [Abstract][Full Text] [Related]
17. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
Glennon RA; Young R
Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
[TBL] [Abstract][Full Text] [Related]
19. Changes in CREB and deltaFosB are associated with the behavioural sensitization induced by methylenedioxypyrovalerone.
Buenrostro-Jáuregui M; Ciudad-Roberts A; Moreno J; Muñoz-Villegas P; López-Arnau R; Pubill D; Escubedo E; Camarasa J
J Psychopharmacol; 2016 Jul; 30(7):707-12. PubMed ID: 27147595
[TBL] [Abstract][Full Text] [Related]
20. Cross-reinstatement between 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using conditioned place preference.
Duart-Castells L; Blanco-Gandía MC; Ferrer-Pérez C; Puster B; Pubill D; Miñarro J; Escubedo E; Rodríguez-Arias M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109876. PubMed ID: 31991149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
